Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection

Capital Medical University

Status: Completed

Conditions: Pituitary Neoplasms

Treatments: Drug: Desflurane; Drug: Propofol

Study type: Interventional

Funder types: Other

Identifiers

NCT05088252

XUAN20211004

Details and patient eligibility

About

Nasal packing is required after endoscopic pituitary adenoma resection. The patient can only breathe through the mouth. The blood and secretion in the nasal cavity may be inhaled into the trachea after the operation. GH-secreting pituitary adenoma causes pharyngeal soft tissue and tongue hypertrophy. These conditions increase the risk of respiratory obstruction and hypoxemia during anesthesia recovery. Propofol total intravenous anesthesia has a rapid effect and a low incidence of nausea and vomiting. Patients anesthetized with desflurane recover quickly is conducive to early recovery of respiratory function and orientation. This study intends to compare the effects of desflurane and propofol on the quality of anesthesia recovery period in patients undergoing endonasal endoscopic pituitary adenoma resection and to provide clinical evidence for the use of desflurane in neurosurgical anesthesia.

Enrollment: 112 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18-65 years;
• Elective endoscopic transsphenoidal resection of pituitary adenomas;
• ASA status I-III;
• Informed consent signed by patients.

Exclusion criteria

• emergency surgery;
• complicated with cerebrovascular disease;
• complicated with pulmonary disease, oxygen saturation below 95% without oxygen;
• expected to retain endotracheal intubation;
• preoperative disturbance of consciousness was not compatible with assessment;
• complicated with primary hypothyroidism;
• previous history of cervical surgery, burns, and radiotherapy;
• BMI >30kg/m2;
• invasive pituitary adenoma with Knosp grade 4.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

112 participants in 2 patient groups

Desflurane Inhalational Anesthesia

Experimental group

Treatment:

Drug: Desflurane

Propofol Total Intravenous Anesthesia

Active Comparator group

Treatment:

Drug: Propofol